Patrick Lao

Dr. Patrick Lao

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Brain Communications
Verified
Journal Article
Open access
PDF file
KLKrystal K Laing
Krystal K Laing
SSSabrina Simoes
Sabrina Simoes
GBGloria P Baena-Caldas
Gloria P Baena-Caldas
PLPatrick Lao
Patrick Lao
MKMilankumar Kothiya
Milankumar Kothiya
FIFor The Alzheimer’s Disease Neuroimaging Initiative
For The Alzheimer’s Disease Neuroimaging Initiative
Small vessel cerebrovascular disease, visualized as white matter hyperintensities on T2-weighted magnetic resonance imaging, contributes to the clinical presentation of Alzheimer’s disease. However, the extent to which cerebrovascular disease represents an independent pathognomonic feature of Alzheimer's disease or directly promotes Alzheimer’s pathology is unclear. The purpose of this study was to examine the association between white matter hyperintensities and plasma levels of tau and to determine if white matter hyperintensities and tau levels interact to predict Alzheimer’s disease diagnosis. To confirm that cerebrovascular disease promotes tau pathology, we examined tau fluid biomarker concentrations and pathology in a mouse model of ischaemic injury. Three hundred ninety-one participants from the Alzheimer’s Disease Neuroimaging Initiative (74.5 ± 7.1 years of age) were included in this cross-sectional analysis. Participants had measurements of plasma total-tau, cerebrospinal fluid beta-amyloid, and white matter hyperintensities, and were diagnosed clinically as Alzheimer’s disease (n = 97), mild cognitive impairment (n = 186) or cognitively normal control (n = 108). We tested the relationship between plasma tau concentration and white matter hyperintensity volume across diagnostic groups. We also examined the extent to which white matter hyperintensity volume, plasma tau, amyloid positivity status and the interaction between white matter hyperintensities and plasma tau correctly classifies diagnostic category. Increased white matter hyperintensity volume was associated with higher plasma tau concentration, particularly among those diagnosed clinically with Alzheimer’s disease. Presence of brain amyloid and the interaction between plasma tau and white matter hyperintensity volume distinguished Alzheimer’s disease and mild cognitive impairment participants from controls with 77.6% and 63.3% accuracy, respectively. In 63 Alzheimer’s Disease Neuroimaging Initiative participants who came to autopsy (82.33 ± 7.18 age at death), we found that higher degrees of arteriosclerosis were associated with higher Braak staging, indicating a positive relationship between cerebrovascular disease and neurofibrillary pathology. In a transient middle cerebral artery occlusion mouse model, aged mice that received transient middle cerebral artery occlusion, but not sham surgery, had increased plasma and cerebrospinal fluid tau concentrations, induced myelin loss, and hyperphosphorylated tau pathology in the ipsilateral hippocampus and cerebral hemisphere. These findings demonstrate a relationship between cerebrovascular disease, operationalized as white matter hyperintensities, and tau levels, indexed in the plasma, suggesting that hypoperfusive injury promotes tau pathology. This potential causal association is supported by the demonstration that transient cerebral artery occlusion induces white matter damage, increases biofluidic markers of tau, and promotes cerebral tau hyperphosphorylation in older-adult mice.

13 June 2015 in Alzheimer's & Dementia
Verified
Journal Article
Closed access
PLPatrick Lao
Patrick Lao
TBTobey J. Betthauser
Tobey J. Betthauser
AHAnsel T. Hillmer
Ansel T. Hillmer
JPJulie C. Price
Julie C. Price
WKWilliam E. Klunk
William E. Klunk
BCBradley Christian
Bradley Christian

9 October 2020 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
PLPatrick Lao
Patrick Lao
JGJosé Gutierrez
José Gutierrez
DKDavid Keator
David Keator
BRBatool Rizvi
Batool Rizvi
ABArit Banerjee
Arit Banerjee
ABAdam M. Brickman
Adam M. Brickman

1 January 2017 in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Verified
Journal Article
Open access
PLPatrick Lao
Patrick Lao
BHBen L. Handen
Ben L. Handen
TBTobey J. Betthauser
Tobey J. Betthauser
IMIulia Mihaila
Iulia Mihaila
SHSigan L. Hartley
Sigan L. Hartley
BCBradley T. Christian
Bradley T. Christian
Introduction: Down syndrome (DS) arises from a triplication of chromosome 21, causing overproduction of the amyloid precursor protein and predisposes individuals to early Alzheimer's disease (AD).Methods: Fifty‐two nondemented adults with DS underwent two cycles of carbon 11‐labeled Pittsburgh compound B ([11C]PiB) and T1 weighted magnetic resonance imaging (MRI) scans 3.0 ± 0.6 years apart. Standard uptake value ratio (SUVR) images (50–70 minutes; cerebellar gray matter [GM]) and GM volumes were analyzed in standardized space (Montreal Neurological Institute space).Results: 85% of PiB(−) subjects remained PiB(−), whereas 15% converted to PiB(+), predominantly in the striatum. None reverted from PiB(+) to PiB(−). Increases in SUVR were distributed globally, but there were no decreases in GM volume. The PiB positivity groups differed in the percent rate of change in SUVR [PiB(−): 0.5%/year, PiB converters: 4.9%/year, and PiB(+): 3.7%/year], but not in GM volume.Discussion: Despite the characteristic striatum‐first pattern, the global rate of amyloid accumulation differs by pre‐existing amyloid burden and precedes atrophy or dementia in the DS population, similar to general AD progression.

14 May 2014 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
YPYajing Peng
Yajing Peng
MLMi Li
Mi Li
BCBen D. Clarkson
Ben D. Clarkson
MPMariana Pehar
Mariana Pehar
PLPatrick Lao
Patrick Lao
LPLuigi Puglielli
Luigi Puglielli
The import of acetyl-CoA into the ER lumen by AT-1/SLC33A1 is essential for the Nε-lysine acetylation of ER-resident and ER-transiting proteins. A point-mutation (S113R) in AT-1 has been associated with a familial form of spastic paraplegia. Here, we report that AT-1S113Ris unable to form homodimers in the ER membrane and is devoid of acetyl-CoA transport activity. The reduced influx of acetyl-CoA into the ER lumen results in reduced acetylation of ER proteins and an aberrant form of autophagy. Mice homozygous for the mutation display early developmental arrest. In contrast, heterozygous animals develop to full term, but display neurodegeneration and propensity to infections, inflammation, and cancer. The immune and cancer phenotypes are contingent on the presence of pathogens in the colony, whereas the nervous system phenotype is not. In conclusion, our results reveal a previously unknown aspect of acetyl-CoA metabolism that affects the immune and nervous systems and the risk for malignancies.

1 February 2024 in Alzheimer's & Dementia
Verified
Journal Article
Open access
SRSamantha M. Rossano
Samantha M. Rossano
AJAubrey S. Johnson
Aubrey S. Johnson
ASAnna Smith
Anna Smith
GZGalen Ziaggi
Galen Ziaggi
ARAndrew Roetman
Andrew Roetman
PLPatrick Lao
Patrick Lao
INTRODUCTION: Evidence suggests microglial activation precedes regional tau and neurodegeneration in Alzheimer's disease (AD). We characterized microglia with translocator protein (TSPO) positron emission tomography (PET) within an AD progression model where global amyloid beta (Aβ) precedes local tau and neurodegeneration, resulting in cognitive impairment.METHODS: Florbetaben, PBR28, and MK‐6240 PET, T1 magnetic resonance imaging, and cognitive measures were performed in 19 cognitively unimpaired older adults and 22 patients with mild cognitive impairment or mild AD to examine associations among microglia activation, Aβ, tau, and cognition, adjusting for neurodegeneration. Mediation analyses evaluated the possible role of microglial activation along the AD progression model.RESULTS: Higher PBR28 uptake was associated with higher Aβ, higher tau, and lower MMSE score, independent of neurodegeneration. PBR28 mediated associations between tau in early and middle Braak stages, between tau and neurodegeneration, and between neurodegeneration and cognition.DISCUSSION: Microglia are associated with AD pathology and cognition and may mediate relationships between subsequent steps in AD progression.